ArticleCell2020
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer.
Patrick A Ott et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
473 papers cite itlatest 60 shown
this papertrialcites it